Ray Dalio's position in Alnylam Pharmaceuticals is currently worth $282 Thousand. That's 0.00% of their equity portfolio (718th largest holding). The first Alnylam Pharmaceuticals trade was made in Q2 2021. Since then Ray Dalio bought shares five more times and sold shares on four occasions. The investor's estimated purchase price is $399 Thousand, resulting in a loss of 29%.